MTIP MedTech Innovation Partners announced the final closing of its fund with a volume of nearly CHF 60 million. In addition to institutional investors, hospitals, foundations and private individuals also participated in the fund.
“A first fund of such a magnitude is exceptional for this industry and a major success for our investors and for us,” said Christoph Kausch, MTIP CEO.
The Basel-based investor will now support around ten start-ups from the medical technology sector and support them in their further development. The two first companies have already been found in the German start-ups Coramaze and Reactive Robotics, and the first investments have already been made.
MTIP is putting special emphasis on patient-related innovations when searching for the next companies and wants its investments to be sustainable in the long-term.
“The close involvement of MTIP in the innovation landscape – starting with university research to practical application in hospitals and through to a good overview of the portfolio strategy of relevant medtech players – is an important success factor for our business model,” said chairperson of the board Felix Grisard.